Načítá se...
Zoledronic acid therapy impacts risk and frequency of skeletal complications and follow-up duration in prostate cancer patients with bone metastasis
PURPOSE: To evaluate the effects of timing and length of zoledronic acid (ZA) treatment on outcomes for patients with prostate cancer in clinical practice. MATERIALS AND METHODS: Patients with prostate cancer and first bone metastasis diagnosed from January 2003 to October 2006 were included. Patien...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3047395/ https://ncbi.nlm.nih.gov/pubmed/21083514 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1185/03007995.2010.535511 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|